Avid Bioservices Inc
NASDAQ:CDMO
Avid Bioservices Inc
Total Equity
Avid Bioservices Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avid Bioservices Inc
NASDAQ:CDMO
|
Total Equity
$44.8m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Equity
-$2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Equity
$22.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Equity
$8.7B
|
CAGR 3-Years
33%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-11%
|
|
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
Total Equity
$233.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
36%
|
CAGR 10-Years
15%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Equity
$18.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
17%
|
CAGR 10-Years
35%
|
|
Avid Bioservices Inc
Glance View
Avid Bioservices, Inc. engages in the commercial manufacturing. The company is headquartered in Tustin, California and currently employs 252 full-time employees. The firm is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The firm provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The firm also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
See Also
What is Avid Bioservices Inc's Total Equity?
Total Equity
44.8m
USD
Based on the financial report for Oct 31, 2024, Avid Bioservices Inc's Total Equity amounts to 44.8m USD.
What is Avid Bioservices Inc's Total Equity growth rate?
Total Equity CAGR 10Y
-3%
Over the last year, the Total Equity growth was -76%. The average annual Total Equity growth rates for Avid Bioservices Inc have been -4% over the past three years , -2% over the past five years , and -3% over the past ten years .
